Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in subjects with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover trial
Journal article published in 2018 by
Stefan Korsatko,
Lene Jensen,
Martina Brunner,
Stefanie Sach-Friedl,
Maja D. Tarp,
Anders G. Holst 
,
Simon R. Heller,
Thomas R. Pieber
,
Simon R. Heller,
Thomas R. Pieber
